News Category
Novogenia AG's H1 2026 revenue fell 7% to EUR 25.7 million, but growth in its core DNA analysis segment and cost reductions signal progress amid strat...
Scientists in South Korea have identified a new protein that regulates the growth of glioblastoma, the deadliest form of brain cancer, potentially lea...
TransCode Therapeutics announced updated Phase 1a results showing that 71.4% of efficacy-evaluable patients achieved stable disease with its lead cand...
Dr. Amar Surdhar, founder of Clarion Psychiatry, has announced his support for the HAS Foundation, highlighting the need for science, innovation, and ...
VERAXA Biotech is advancing its oncology pipeline and seeking industrial partnerships after completing its business combination and Nasdaq listing, ac...
The increasing personalization of cancer treatments, driven by immunotherapies and other innovations, is making cancer care more complex for patients ...
Creative Biolabs has broadened its specialized antibody offerings for HIV-1, HIV-2, and HTLV-1, providing researchers with new tools to study viral pr...
Quantum BioPharma is developing Lucid-MS, a drug candidate that targets an enzyme to inhibit demyelination, offering a new approach to treating multip...
Kairos Pharma's President and Chief Scientific Officer will present and moderate at a major drug discovery conference, highlighting the company's stra...
A new international study finds that waist-to-height ratio is a reliable, low-cost screening tool for pediatric MASLD across diverse ethnic and geneti...
VERAXA Biotech (NASDAQ: VRXA) is advancing its oncology pipeline centered on the BiTAC platform, following its NASDAQ listing and key executive appoin...
Quantum BioPharma is developing Lucid-MS, a drug candidate that targets an enzyme to inhibit demyelination, offering a potential new path for multiple...
TransCode Therapeutics has expanded its global intellectual property portfolio with new patent allowances in Australia and Japan, reinforcing its posi...
Lantern Pharma received a USPTO Notice of Allowance for a patent covering LP-284 to treat mantle cell lymphoma and other blood cancers, potentially ex...
The American Heart Association and American Headache Society have co-funded a $200,000 Innovative Project Award to investigate the link between migrai...
A new injectable nanodevice technology developed at MIT Media Lab has demonstrated the ability to kill over half of malignant cells in recurrent brain...
VERAXA Biotech is progressing its BiTAC platform and oncology pipeline after joining NASDAQ, with recent executive appointments strengthening its deve...
GeoVax announced preclinical findings that its enhanced MVA-X vaccine provides durable single-dose protection against highly pathogenic Clade I mpox, ...
Onco-Innovations is advancing its preclinical cancer candidate ONC010 toward first-in-human testing by integrating manufacturing, formulation, preclin...
Medical experts are urging small cell lung cancer patients to ask about clinical trials at their first appointment, as emerging treatments offer new h...
Telomir Pharmaceuticals (NASDAQ: TELO) announced peer-reviewed preclinical research showing its lead candidate Telomir-Zn improved visual function and...
Scientists are investigating accelerated biological aging as a potential explanation for the increasing incidence of cancer in adults under 55, a tren...
VolitionRx has joined a €6.3 million French government-funded consortium to develop an early sepsis detection test using its Nu.Q NETs biomarker, targ...
VERAXA Biotech has named Raju Willener as CFO, bringing over 30 years of capital markets experience as the company advances its BiTAC oncology platfor...
A new American Heart Association scientific statement reveals that women's chronic kidney disease is frequently undiagnosed and undertreated, calling ...
Telomir Pharmaceuticals announced new research findings showing its lead drug candidate Telomir-Zn inhibited growth in human and canine osteosarcoma c...
Dr. Wael Sakr, a prominent pathologist and dean, has announced a one-time $1,000 scholarship to support undergraduate pre-med students across the Unit...
Creative Biolabs has expanded its single-cell multi-omics and RNA sequencing solutions to help researchers overcome sample processing challenges and a...
A new review reveals that the tumor microenvironment drives natural killer cells into diverse functional subsets, offering a framework for more precis...
The September 17 Life Sciences Virtual Investor Forum will feature seven companies presenting live across oncology, fibrosis, drug delivery, antibioti...
VERAXA Biotech has named Dr. Christoph Erkel as chief scientific officer to lead the advancement of its BiTAC® technology and oncology pipeline, a mov...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor for multiple sclerosis, is moving toward a Phase 2 trial following FDA clea...
Onco-Innovations' CMO detailed the company's novel PNKP-targeting cancer drug ONC010, which uses synthetic lethality and nanoparticle delivery to pote...
Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial in multiple sclerosis, marking a significant step for a novel treatment ap...
Kairos Pharma's CEO will present at the H.C. Wainwright conference, highlighting its lead candidate ENV-105 designed to overcome cancer drug resistanc...
GeoVax applauds the new Gavi-funded global mpox vaccine stockpile as a step toward sustained preparedness, while highlighting its GEO-MVA candidate's ...
VERAXA Biotech (NASDAQ: VRXA) has named veteran financial executive Raju Willener as CFO, effective immediately, to support its capital strategy and a...
Onco-Innovations Ltd. advances its oncology pipeline with key milestones in manufacturing, IND-enabling activities, partnerships, and funding, positio...
OS Animal Health, a subsidiary of OS Therapies, showcased its innovative HER2-targeting immunotherapy for canine osteosarcoma at the Moody Capital Sol...
Quantum BioPharma's FDA clearance to test Lucid-MS in phase 2 trials marks a potential breakthrough in multiple sclerosis treatment by targeting myeli...
A new study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in brain cancer tre...
Quantum BioPharma's Lucid-MS, a first-in-class drug candidate for multiple sclerosis, has received FDA clearance for Phase 2 trials, potentially marki...
NanoViricides has registered its Phase II clinical trial for NV-387 Oral Gummies as a treatment for Ebola in the Democratic Republic of Congo, marking...
Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial in MS, marking a step toward a targeted treatment for demyelination.
New federal data shows youth tobacco use at historic lows, while FDA's recent authorization of ZYN nicotine pouches offers adult smokers a scientifica...
A large study reveals that colorectal cancer patients who develop brain metastases have shorter survival, with timing significantly impacting prognosi...
Onco-Innovations reports significant progress in developing ONC010, a PNKP inhibitor for cancer therapy, including high-purity API production and plan...
VERAXA Biotech AG (NASDAQ: VRXA) has appointed Raju Willener as CFO to lead its capital strategy and support the development of its proprietary BiTAC(...
